Phone:
(+212)6814-6992
Physical address:
Cardioplus, Green street, Casablanca, Morocco.
ELUVIA™ – Drug-Eluting Vascular Stent System
The Eluvia™ Drug-Eluting Vascular Stent System is engineered to provide sustained drug release for the treatment of peripheral artery disease (PAD). Utilizing a unique polymer to control drug elution, Eluvia™ ensures consistent and durable outcomes, particularly in complex lesions.
Benefits
- Exceptional Outcomes: Demonstrates high primary patency rates and low target lesion revascularization (TLR) rates.
- Polymer Design: Controls drug release over up to one year, minimizing downstream particulates.
- Comprehensive Coverage: Available in multiple lengths up to 150mm, providing extensive lesion coverage.
- Proven Performance: High-grade nitinol tubing enhances durability and fracture resistance.
- Ease of Use: Ergonomic handle with thumb wheel and pull grip for precise deployment.
Technical Parameters
- Stent Diameters: 6 and 7 mm
- Stent Lengths: 40, 60, 80, 100, 120, 150 mm
- Catheter Length: 130 cm
- Guide Wire Compatibility: 0.035″
Clinical Data
Gray, William A. « CRT-300.01 Five-Year Results From the IMPERIAL Randomized Study of Eluvia and Zilver PTX Drug-Eluting Stents and the Long Lesion Sub-Study for Femoropopliteal Artery Disease ». Cardiovascular Interventions, 27 février 2023. https://doi.org/10.1016/j.jcin.2023.01.179
